Rare diseases
Investigational molecules
Locations
A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
PortugalTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
PortugalA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
PortugalStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
PortugalStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PortugalLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
PortugalStudy on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps
PortugalStudy on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease
PortugalStudy on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury
PortugalStudy of ISIS 678354 for Patients with Severe High Triglycerides
PortugalStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
PortugalStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
